SEMA6C: A Protein Implicated in Neurodegenerative and Autoimmune Diseases

Target Name: SEMA6C

NCBI ID: G10500

SEMA6C

SEMA6C: A Protein Implicated in Neurodegenerative and Autoimmune Diseases

SEMA6C, also known as m-SemaY, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SEMA family of proteins, which are involved in the regulation of cell signaling pathways. SEMA6C has been shown to play a role in the development and progression of a number of diseases, including neurodegenerative disorders, autoimmune diseases, and kidney disease. As a result, SEMA6C has become a promising drug target and potential biomarker for a variety of diseases.

SEMA6C is a transmembrane protein that is expressed in a variety of tissues, including the brain, heart, and kidneys. It is a member of the SEMA family of proteins, which are involved in the regulation of cell signaling pathways. The SEMA6C gene is located on chromosome 6 and encodes a protein that is 21 kDa in size. SEMA6C is expressed in a variety of tissues and has been shown to play a role in the development and progression of a number of diseases.

One of the most promising aspects of SEMA6C is its role in the development of neurodegenerative disorders. neurodegenerative disorders are a group of diseases that are characterized by the progressive loss of neural cells and the damage to neural tissue that results. Some of the most common neurodegenerative disorders include Alzheimer's disease, Parkinson's disease, and Huntington's disease. SEMA6C has been shown to play a role in the development and progression of these disorders by regulating the activity of neural stem cells and promoting the growth of neuroblasts, which are a type of cell that is responsible for the development and maintenance of the nervous system.

In addition to its role in neurodegenerative disorders, SEMA6C has also been shown to be involved in the development and progression of autoimmune diseases. Autoimmune diseases are a group of diseases in which the immune system attacks the body's own tissues and causes inflammation and damage. Some of the most common autoimmune diseases include rheumatoid arthritis, lupus, and multiple sclerosis. SEMA6C has been shown to play a role in the development and progression of these diseases by regulating the activity of immune cells and promoting the growth of immune organs.

SEMA6C has also been shown to be involved in the development and progression of kidney disease. Chronic kidney disease is a serious condition that can be caused by a variety of factors, including aging, diabetes, and hypertension. SEMA6C has been shown to play a role in the development and progression of chronic kidney disease by regulating the activity of immune cells and promoting the growth of damaged kidney cells.

In conclusion, SEMA6C is a protein that is expressed in various tissues of the body and has been shown to play a role in the development and progression of a number of diseases. As a result, SEMA6C has become a promising drug target and potential biomarker for a variety of diseases. Further research is needed to fully understand the role of SEMA6C in these diseases and to develop effective treatments.

Protein Name: Semaphorin 6C

Functions: Shows growth cone collapsing activity on dorsal root ganglion (DRG) neurons in vitro. May be a stop signal for the DRG neurons in their target areas, and possibly also for other neurons. May also be involved in the maintenance and remodeling of neuronal connections

The "SEMA6C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEMA6C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets